PRICE T ROWE ASSOCIATES INC /MD/
Position in STOK — Stoke Therapeutics, Inc.
CIK 80255
BALTIMORE, MD
Position in STOK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$87,092,099
+$24,115,492 QoQ
Shares Held
2,661,739
+37.6% QoQ
Ownership
4.13%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#11
of 198 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in STOK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,962,932 across 304 Biotechnology names. STOK ranks #51 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in STOK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $87,092,099 | 2,661,739 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $62,976,607 | 1,934,171 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $11,817,880 | 372,334 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,204,680 | 51,263 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $496,392 | 43,735 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $260,001 | 39,098 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $413,128 | 37,455 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $433,099 | 35,240 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $473,471 | 35,046 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $424,318 | 31,431 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $156,690 | 29,789 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $117,368 | 29,789 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,815,340 | 358,922 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,147,082 | 377,801 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,646,836 | 395,107 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,294,484 | 412,343 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,504,884 | 416,721 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $8,922,316 | 423,863 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $10,513,545 | 438,247 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $8,588,086 | 337,582 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $13,040,658 | 387,423 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $24,204,777 | 623,192 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $46,424,338 | 749,626 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $12,394,414 | 370,093 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $9,326,061 | 391,358 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $9,790,253 | 427,522 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||